VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization

Clinical trial NCT06873321 · RECRUITING

Trial details

NCT number: NCT06873321
Sponsor: Science Valley Research Institute
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Peripheral Arterial Disease Venous Thormboembolism Cardiovascular Diseases Vascular Surgery Patient with PAD / Carotid Stenosis

Start date: 2024-02-24
Primary completion: 2025-07-20
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.